Cerevel Therapeutics Holdings, Inc.

NEW YORK LIFE INVESTMENT MANAGEMENT LLC

Report date

6/30/2024

Quarter

2024 Q2

Filed

8/5/2024

Shares

178,765

Value ($000)

7,310

Weight

0.1%

2024 Q1 - 2024 Q2 (2 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2024 Q2	8/5/2024	7,310	0.1%	178,765	6/30/2024
2024 Q1	5/6/2024	6,165	0.1%	145,842	3/31/2024